Literature DB >> 12081660

Effect of systemic nitroglycerin on CGRP and 5-HT afferents to rat caudal spinal trigeminal nucleus and its modulation by estrogen.

A Pardutz1, S Multon, B Malgrange, A Parducz, L Vecsei, J Schoenen.   

Abstract

Systemic administration of nitroglycerin, a nitric oxide donor, triggers in migraine patients a delayed attack of unknown mechanism. After puberty migraine is more prevalent in women. Attacks can be triggered by abrupt falls in plasma estrogen levels, which accounts in part for sexual dimorphism, but lacks an established neurobiological explanation. We studied the effect of nitroglycerin on the innervated area of calcitonin gene-related peptide (CGRP) and serotonin-immunoreactive afferents to the superficial laminae of the spinal portion of trigeminal nucleus caudalis, and its modulation by estrogen. In male rats, nitroglycerin produced after 4 h a significant decrease of the area innervated by CGRP-immunoreactive afferents and an increase of that covered by serotonin-immunoreactive fibres. These effects were not observed in the superficial laminae of thoracic dorsal horns. The effect of nitroglycerin was similar in ovariectomized females. In estradiol-treated ovariectomized females the area in the spinal portion of trigeminal nucleus caudalis laminae I-II covered by CGRP-immunoreactive fibres was lower and that of serotonin-immunoreactive fibres was higher than in males and for both transmitters not significantly changed after nitroglycerin. The bouton size of CGRP profiles was smaller in estradiol-treated ovariectomized females, whereas after nitroglycerin it decreased significantly but only in males and ovariectomized females. Nitroglycerin, i.e. nitric oxide, is thus able to differentially influence afferent fibres in the superficial laminae of rat spinal trigeminal nucleus caudalis. Estradiol modulates the basal expression of these transmitters and blocks the nitroglycerin effect. These data may contribute to understanding the mechanisms by which estrogens influence migraine severity and the triggering of attacks by nitric oxide.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12081660     DOI: 10.1046/j.1460-9568.2002.02031.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  20 in total

1.  Interactions of estradiol and NSAIDS on carrageenan-induced hyperalgesia.

Authors:  Deirtra A Hunter; Gordon A Barr; Kai-Yvonne Shivers; Nicole Amador; Shirzad Jenab; Charles Inturrisi; Vanya Quinones-Jenab
Journal:  Brain Res       Date:  2011-01-31       Impact factor: 3.252

Review 2.  Transdermal hormonal therapy in perimenstrual migraine: why, when and how?

Authors:  Cristina Tassorelli; Rosaria Greco; Marta Allena; Erica Terreno; Rossella E Nappi
Journal:  Curr Pain Headache Rep       Date:  2012-10

3.  Pre-treatment with new kynurenic acid amide dose-dependently prevents the nitroglycerine-induced neuronal activation and sensitization in cervical part of trigemino-cervical complex.

Authors:  Annamária Fejes-Szabó; Zsuzsanna Bohár; Enikő Vámos; Gábor Nagy-Grócz; Lilla Tar; Gábor Veres; Dénes Zádori; Márton Szentirmai; János Tajti; István Szatmári; Ferenc Fülöp; József Toldi; Árpád Párdutz; László Vécsei
Journal:  J Neural Transm (Vienna)       Date:  2014-01-03       Impact factor: 3.575

Review 4.  Migraine is a neuronal disease.

Authors:  J Tajti; A Párdutz; E Vámos; B Tuka; A Kuris; Zs Bohár; A Fejes; J Toldi; L Vécsei
Journal:  J Neural Transm (Vienna)       Date:  2010-12-15       Impact factor: 3.575

5.  Estradiol-induced antinociceptive responses on formalin-induced nociception are independent of COX and HPA activation.

Authors:  Deirtra A Hunter; Gordon A Barr; Nicole Amador; Kai-Yvonne Shivers; Lynne Kemen; Christopher M Kreiter; Shirzad Jenab; Charles E Inturrisi; Vanya Quinones-Jenab
Journal:  Synapse       Date:  2011-02-25       Impact factor: 2.562

Review 6.  Pathophysiology of Migraine: A Disorder of Sensory Processing.

Authors:  Peter J Goadsby; Philip R Holland; Margarida Martins-Oliveira; Jan Hoffmann; Christoph Schankin; Simon Akerman
Journal:  Physiol Rev       Date:  2017-04       Impact factor: 37.312

Review 7.  Migraine: where and how does the pain originate?

Authors:  Karl Messlinger
Journal:  Exp Brain Res       Date:  2009-03-14       Impact factor: 1.972

Review 8.  Animal migraine models for drug development: status and future perspectives.

Authors:  Inger Jansen-Olesen; Peer Tfelt-Hansen; Jes Olesen
Journal:  CNS Drugs       Date:  2013-12       Impact factor: 5.749

Review 9.  New theories in the pathogenesis of menstrual migraine.

Authors:  Vincent T Martin
Journal:  Curr Pain Headache Rep       Date:  2008-12

10.  NMDA receptor blockade reduces temporomandibular joint-evoked activity of trigeminal subnucleus caudalis neurons in an estrogen-dependent manner.

Authors:  A Tashiro; K Okamoto; D A Bereiter
Journal:  Neuroscience       Date:  2009-09-30       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.